Obstetrics/Gynecology
RSSArticles
-
Dating Pregnancy: What Is the Most Accurate Method?
The NICHD Fetal Growth Studies – Singletons investigation recently yielded a new formula for determining gestational age based on standard biometric information. When compared to an often-used formula, it appeared to be more accurate after 21 weeks of gestation.
-
What Do the Urinary Microbiota and Incontinence Have to Do With Each Other?
Increased diversity of the microbiota in women is associated with urgency urinary incontinence symptoms but not with stress urinary incontinence symptoms.
-
New Rules Undermine Federal Contraceptive Coverage Guarantee
The regulations leave the coverage guarantee in place, but greatly extend exemptions.
-
Griffithsin Considered as Potential Multipurpose Prevention Technology Option
Researchers now are focusing on an investigational multipurpose prevention technology comprised of griffithsin in a carrageenan gel. While research is in the early stages, the combination approach may lead to a new option to prevent HIV and STIs in an on-demand or sustained use format.
-
Counsel Women About Contraception Guidelines After Bariatric Surgery
Just-published research indicates that while women should avoid conception for the first 18 months following bariatric surgery, 42% of women participating in the 10-site study reported having unprotected intercourse during the 18-month at-risk, post-surgical timeframe.
-
Research Update: Human Papillomavirus Vaccine Safe for Adult Women
In a study of more than 3 million adult women in Denmark and Sweden, results indicate that human papillomavirus (HPV) vaccination was not connected with 44 serious chronic diseases.
-
Intrauterine Device Use Linked With Decrease in Cervical Cancer Incidence
Results of a just-published systematic review indicate that in women who used an intrauterine device, the incidence of cervical cancer was one-third lower.
-
Time to Update Your Knowledge of Long-Acting Reversible Contraceptives
Practice bulletin says intrauterine, implant options are safe and effective for almost all women.
-
Update on Postpartum Hemorrhage
In the United States, postpartum hemorrhage accounts for 11.4% of maternal deaths, the fourth most common cause after cardiovascular diseases, non-cardiovascular diseases, and infection; worldwide, it is the leading cause of maternal mortality. This feature will discuss the latest treatments for managing postpartum hemorrhage.
-
Hormone Replacement: Have We Made Progress Since WHI?
Vaginal estrogen may improve vaginal symptoms of menopause and does not increase the risk for endometrial cancer, stroke, or cardiovascular disease.